vs
Side-by-side financial comparison of HARROW, INC. (HROW) and Ouster, Inc. (OUST). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $62.2M, roughly 1.4× Ouster, Inc.). On growth, Ouster, Inc. posted the faster year-over-year revenue change (106.6% vs 33.3%). HARROW, INC. produced more free cash flow last quarter ($8.1M vs $-37.2M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 54.8%).
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Ouster, Inc. is an American lidar technology company headquartered in San Francisco, California. It builds high-resolution, digital 3D lidar sensors for use in autonomous vehicles, industrial, robotics, drones, mapping, defense, and security systems.
HROW vs OUST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $89.1M | $62.2M |
| Net Profit | $6.6M | — |
| Gross Margin | 79.3% | 60.2% |
| Operating Margin | 17.5% | 1.5% |
| Net Margin | 7.4% | — |
| Revenue YoY | 33.3% | 106.6% |
| Net Profit YoY | -2.2% | — |
| EPS (diluted) | $0.20 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $89.1M | $62.2M | ||
| Q3 25 | $71.6M | $39.5M | ||
| Q2 25 | $63.7M | $35.0M | ||
| Q1 25 | $47.8M | $32.6M | ||
| Q4 24 | $66.8M | $30.1M | ||
| Q3 24 | $49.3M | $28.1M | ||
| Q2 24 | $48.9M | $27.0M | ||
| Q1 24 | $34.6M | $25.9M |
| Q4 25 | $6.6M | — | ||
| Q3 25 | $1.0M | $-21.7M | ||
| Q2 25 | $5.0M | $-20.6M | ||
| Q1 25 | $-17.8M | $-22.0M | ||
| Q4 24 | $6.8M | — | ||
| Q3 24 | $-4.2M | $-25.6M | ||
| Q2 24 | $-6.5M | $-23.9M | ||
| Q1 24 | $-13.6M | $-23.8M |
| Q4 25 | 79.3% | 60.2% | ||
| Q3 25 | 75.3% | 42.1% | ||
| Q2 25 | 74.5% | 45.2% | ||
| Q1 25 | 67.5% | 41.3% | ||
| Q4 24 | 78.8% | 43.8% | ||
| Q3 24 | 75.6% | 38.3% | ||
| Q2 24 | 74.4% | 33.7% | ||
| Q1 24 | 69.5% | 28.6% |
| Q4 25 | 17.5% | 1.5% | ||
| Q3 25 | 20.6% | -61.4% | ||
| Q2 25 | 17.9% | -76.5% | ||
| Q1 25 | -23.5% | -73.0% | ||
| Q4 24 | 19.3% | -85.1% | ||
| Q3 24 | 2.7% | -98.0% | ||
| Q2 24 | 3.1% | -93.6% | ||
| Q1 24 | -20.0% | -99.5% |
| Q4 25 | 7.4% | — | ||
| Q3 25 | 1.4% | -55.0% | ||
| Q2 25 | 7.8% | -58.8% | ||
| Q1 25 | -37.2% | -67.5% | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | -8.6% | -91.1% | ||
| Q2 24 | -13.2% | -88.4% | ||
| Q1 24 | -39.2% | -91.9% |
| Q4 25 | $0.20 | $0.10 | ||
| Q3 25 | $0.03 | $-0.37 | ||
| Q2 25 | $0.13 | $-0.38 | ||
| Q1 25 | $-0.50 | $-0.42 | ||
| Q4 24 | $0.19 | $-0.46 | ||
| Q3 24 | $-0.12 | $-0.54 | ||
| Q2 24 | $-0.18 | $-0.53 | ||
| Q1 24 | $-0.38 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $72.9M | $208.6M |
| Total DebtLower is stronger | $250.0M | — |
| Stockholders' EquityBook value | $52.4M | $261.7M |
| Total Assets | $399.5M | $349.5M |
| Debt / EquityLower = less leverage | 4.77× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $72.9M | $208.6M | ||
| Q3 25 | $74.3M | $244.5M | ||
| Q2 25 | $53.0M | $226.5M | ||
| Q1 25 | $66.7M | $168.2M | ||
| Q4 24 | $47.2M | $172.0M | ||
| Q3 24 | $72.6M | $151.4M | ||
| Q2 24 | $71.0M | $184.2M | ||
| Q1 24 | $76.0M | $187.8M |
| Q4 25 | $250.0M | — | ||
| Q3 25 | $347.2M | — | ||
| Q2 25 | $250.6M | — | ||
| Q1 25 | $256.9M | — | ||
| Q4 24 | $262.7M | — | ||
| Q3 24 | $230.7M | — | ||
| Q2 24 | $236.3M | — | ||
| Q1 24 | $243.4M | — |
| Q4 25 | $52.4M | $261.7M | ||
| Q3 25 | $47.0M | $247.4M | ||
| Q2 25 | $49.7M | $221.0M | ||
| Q1 25 | $56.5M | $167.9M | ||
| Q4 24 | $69.7M | $180.9M | ||
| Q3 24 | $58.0M | $171.7M | ||
| Q2 24 | $58.5M | $170.6M | ||
| Q1 24 | $60.6M | $167.2M |
| Q4 25 | $399.5M | $349.5M | ||
| Q3 25 | $363.1M | $353.8M | ||
| Q2 25 | $345.0M | $321.8M | ||
| Q1 25 | $364.2M | $268.6M | ||
| Q4 24 | $389.0M | $276.1M | ||
| Q3 24 | $351.5M | $255.2M | ||
| Q2 24 | $306.6M | $309.9M | ||
| Q1 24 | $295.5M | $317.7M |
| Q4 25 | 4.77× | — | ||
| Q3 25 | 7.39× | — | ||
| Q2 25 | 5.05× | — | ||
| Q1 25 | 4.55× | — | ||
| Q4 24 | 3.77× | — | ||
| Q3 24 | 3.98× | — | ||
| Q2 24 | 4.04× | — | ||
| Q1 24 | 4.02× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.4M | $-15.4M |
| Free Cash FlowOCF − Capex | $8.1M | $-37.2M |
| FCF MarginFCF / Revenue | 9.1% | -59.8% |
| Capex IntensityCapex / Revenue | 0.4% | 35.0% |
| Cash ConversionOCF / Net Profit | 1.27× | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.0M | $-64.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.4M | $-15.4M | ||
| Q3 25 | $16.6M | $-18.3M | ||
| Q2 25 | $-803.0K | $-1.3M | ||
| Q1 25 | $19.7M | $-4.9M | ||
| Q4 24 | $-17.8M | $-2.6M | ||
| Q3 24 | $3.0M | $-3.8M | ||
| Q2 24 | $-2.7M | $-21.6M | ||
| Q1 24 | $-4.6M | $-5.7M |
| Q4 25 | $8.1M | $-37.2M | ||
| Q3 25 | $16.4M | $-20.0M | ||
| Q2 25 | $-969.0K | $-2.2M | ||
| Q1 25 | $19.5M | $-5.4M | ||
| Q4 24 | $-18.3M | $-4.0M | ||
| Q3 24 | $2.3M | $-4.3M | ||
| Q2 24 | $-3.1M | $-22.0M | ||
| Q1 24 | $-4.7M | $-7.1M |
| Q4 25 | 9.1% | -59.8% | ||
| Q3 25 | 22.9% | -50.7% | ||
| Q2 25 | -1.5% | -6.3% | ||
| Q1 25 | 40.8% | -16.6% | ||
| Q4 24 | -27.4% | -13.3% | ||
| Q3 24 | 4.8% | -15.4% | ||
| Q2 24 | -6.3% | -81.5% | ||
| Q1 24 | -13.6% | -27.4% |
| Q4 25 | 0.4% | 35.0% | ||
| Q3 25 | 0.3% | 4.3% | ||
| Q2 25 | 0.3% | 2.5% | ||
| Q1 25 | 0.4% | 1.7% | ||
| Q4 24 | 0.8% | 4.8% | ||
| Q3 24 | 1.2% | 2.0% | ||
| Q2 24 | 0.7% | 1.3% | ||
| Q1 24 | 0.3% | 5.3% |
| Q4 25 | 1.27× | — | ||
| Q3 25 | 16.26× | — | ||
| Q2 25 | -0.16× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -2.62× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
